留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

核辐射事故伤药物防治研究进展

刘玉明,  张术,  储智勇

downloadPDF
文章导航 > 药学实践与服务  > 2011 >  29(5): 321-323,346
刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
shu
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
shu

核辐射事故伤药物防治研究进展

  • 海军医学研究所,上海 200433

Advances on the medication of nuclear Radiation Accidents

  • Naval Medical Research Institute , Shanghai 200433, China

  • 摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。
    Abstract: With the increasing competition of nuclear arms in the world and the newly emerging of nuclear technological research methods, nuclear radiation had resulted in tremendous injuries for human being. How to strengthen the emergency protection and the medical remedy for the nuclear accidents and the radiation injuries had become an important question . Based on the clinical manifestation of the nuclear radiation, the advance on the medicine of prevention and therapy in nuclear radiation accidents in the aspects of combined modality therapy, cytokine, sulfhydryl compounds and herbs were reviewed. The development and utilization of antiradiation drug were prospected.
  • [1] Fliedner TM,Graessle D,Meineke V,et al.Pathophysiological principles underlying the blood cell concentration responses used to assess the severity of efect after accidental whole body radiation exposure:an essential basis for an evidence.based clinical triage[J].Exp Hematol,2007,35(4 Suppl 1):8.
    [2] Heimers A,Brede HJ,Giesen U,et al.Chromosome aberration analysis and the influence of mitotic delay after simulated partial-body exposure with hi gh doses uf sparsely and densely ionizing radiation[J].Radiat Environ Biophys,2006,45(1):45.
    [3] Hande MP,Azizuva TV,Burak LE,et al.Complex chromosome aberrations persist in individuals man y years after occupational exposure to densely ionizing radiation:an mF1SH study[J].Genes Chromosomes Cancer,2005,44(1):1.
    [4] Wang Y,Schulte BA,Zhou D.Hematopoietic stem cell senescence and long-term bone marrow injury[J].Cell Cycle,2006,5(1):35.
    [5] Wang Y,Schulte BA,LaRue AC,et al.Total body irradiation selectively induces murine hematopoietic stem cell senescence[J].Blood, 2006.107(1):358.
    [6] Liu YJ,Lu SH,Xu B,et al. Hemangiopoietin,a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages[J].Blood,2004,103(12):4449.
    [7] Herodin F,Drouet M.Cytokine-based treatment of accidentally irradiated victims and new approaches[J].Exp Hematol,2005,33(10),1071.
    [8] Hosseinimehr SJ, Zakaryaee V, Frouhgizaden M. Oral oxymetholone reduces mortality induced by gamma irradiation in mice through stimulation of hematopoietic cells[J]. Mol Cell Biochem,2006,287:193.
    [9] Drouet M,Mourcin F,Grenier N,et al.Single administration of stemcell factor.FL -3 ligand.megakaryocyte growth and developmentfactor.and interleukin-3 in combination soon after irradiationprevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J].Blood,2004,103(3):878.
    [10] Demirel C, Kilciksiz S, Ay OI,et al. Effect of N-acetylcysteine on radiation-induced genotoxicity and cytotoxicity in rat bone marrow[J]. Journal-of-radiation-research,2009,50(1): 43.
    [11] Demirel C, Kilciksiz S,Evirgen S,et al. The preventive effect of N-acetylcysteine on radiation-induced dermatitis in a rat model[J]. J-BUON. 2010 ,15(3): 577.
    [12] Murley J S, Kataoka Y,Baker KL,et al. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha[J]. Radiation-research,2007 ,167(4): 465.
    [13] You WC, Lin WC, Huang JT ,et al.Indigowood root extract protects hematopoietic cells reduces tissue damage and modulates inflammatory cytokines after total-body irradiation: does Indirubin play a role in radioprotection[J]. Phytomedicine,2009 ,16(12): 1105.
    [14] Liu WC, Wang SC,Tsai ML, et al.Protection against radiation-induced bone marrow and intestinal injuries by Cordyceps sinensis, a Chinese herbal medicine[J]. Radiat-Res, 2006 , 166(6): 900.
    [15] 陆兴熠 ,刘剑英,钟进义. 葡多酚对核辐射接触人员氧化损伤防护作用[J]. 中国公共卫生,2008,24(9):1072.
    [16] Goel HC, Bala M, Prasad J,et al,Radioprotection by Rhodiola imbricate in mice against whole-body lethal irradiation[J]. J Med Food. 2006 , 9(2): 154.
    [17] 梁 莉,王 婷,乔 华,等.南沙参多糖的药理作用研究进展[J]. 西北药学杂志,2008,(23) 5:334.
    [18] Li Z,Wenyi Z,Liang'an Z. General situation of radiation accidents in China[J]. Radiat Prot Dosimety,2007,124(2):177.
    [19] Weisdorf D,ChaoN,Waelenko JK,et al.Acute radiation injury:contingency planning for triage,supportive care,and transplantation[J]. Biol Blood Marrow Transplant, 2006,12(6):672.
    [20] Rencova J, Vlkova A, Vesela G. Improved chelation therapy of intramuscularly deposited horium by CaDTPA in the rat [J]. Radiat Prot Dosim, 2003, 105 : 513.
    [21] Martinez AB, Mandalunis PM, Bozal CB, et al. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1, 1-bisphosphonate ( EHBP) [J]. Health Phys, 2003, 85(3):343.
    [22] Benkovic V, Knezevic AH, Dikic D, et al. Radioprotective effects of quercetin and ethanolic extract of propolis in gamma-irradiated mice[J]. Arh Hig Rada Toksikol, 2009 , 60(2): 129.
    [23] Srinivasan M, Devipriya N, Kalpana KB, et al. Lycopene: An antioxidant and radioprotector against gamma-radiation-induced cellular damages in cultured human lymphocytes[J]. Toxicology, 2009, 262(1): 43.
    [24] Goel A, Aggarwal BB. Curcumin the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs[J]. Nutr Cancer, 2010, 62(7): 919.
  • [1] 姚一青, 方家豪, 马荟琳, 王璇, 吕狄亚.  抗辐射天然产物研究进展 . 药学实践与服务, 2022, 40(5): 427-432. doi: 10.12206/j.issn.2097-2024.202101033
    [2] 王静, 章越凡, 李铁军.  辐射防护相关信号通路研究现状 . 药学实践与服务, 2017, 35(1): 8-11. doi: 10.3969/j.issn.1006-0111.2017.01.003
    [3] 杨宏, 倪敏, 赵心彬, 陶霞.  辐射致组织损伤凋亡机制的研究概况 . 药学实践与服务, 2014, 32(2): 96-97,149. doi: 10.3969/j.issn.1006-0111.2014.02.005
    [4] 徐岩成, 方一杰, 阎澜, 姜远英, 曹永兵.  降脂药物的肝脏毒性及其防治策略研究进展 . 药学实践与服务, 2014, 32(6): 412-415,464. doi: 10.3969/j.issn.1006-0111.2014.06.004
    [5] 王庆宾, 韩婷, 孙连娜, 尚雯.  抗辐射的天然药物研究进展 . 药学实践与服务, 2012, 30(3): 171-174,177. doi: 10.3969/j.issn.1006-0111.2012.03.005
    [6] 张佳音, 舒丽芯, 陈盛新, 栾潇潇, 田甜.  核辐射伤防治药品的信息熵储备模型研究 . 药学实践与服务, 2008, (2): 120-122.
    [7] 邬蓉, 高守红, 辛海量.  人参抗辐射损伤研究概况 . 药学实践与服务, 2007, (6): 364-366,392.
    [8] 陈巧玲, 蔡宝祥.  他汀类药物防治动脉粥样硬化作用研究进展 . 药学实践与服务, 2006, (6): 321-324.
    [9] 蒯丽萍, 顾文华, 陈静.  FDA防治吸入性炭疽病的抗微生物药物研发指南 . 药学实践与服务, 2004, (5): 305-307.
    [10] 戴德银, 赵俊, 卢海波, 王萍.  浅析目前抗“非典”的药物 . 药学实践与服务, 2003, (5): 271-274.
    [11] 王文俭, 蒋雪涛, 郭涛, 董志超.  辐射法制备喃氟啶植入剂的家兔药物动力学 . 药学实践与服务, 2000, (1): 19-21.
    [12] 于天杰, 赵国景, 冀建明.  偏头痛的发病及药物防治进展 . 药学实践与服务, 1997, (1): 10-12.
    [13] 王昱, 王子立, 周丽芳.  中药在防治辐射损伤中的应用 . 药学实践与服务, 1996, (5): 317-319.
    [14] 路绪文, 高明全.  八起药疗事故应吸取的教训 . 药学实践与服务, 1995, (2): 123-124.
    [15] 黄循裕.  一起药疗事故分析 . 药学实践与服务, 1992, (2): 20-20.
    [16] 何廉卿.  临床药物不良反应及其防治 . 药学实践与服务, 1991, (4): 48-50.
    [17] 吴健, 杨爱梅.  防治褥疮液治疗褥疮51例 . 药学实践与服务, 1989, (1): 36-37.
    [18] 陈崇尚.  抗辐射中药"益康片"通过鉴定 . 药学实践与服务, 1988, (2): 85-85.
    [19] 黄榜祖, 贺逢鸣.  药疗事故纪实 . 药学实践与服务, 1988, (2): 28-29.
    [20] 陆晓和.  西米替丁的不良反应及其防治 . 药学实践与服务, 1986, (4): 34-36.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  2141
  • HTML全文浏览量:  217
  • PDF下载量:  449
  • 被引次数: 0
出版历程
  • 收稿日期:  2010-11-15
  • 修回日期:  2011-04-19

核辐射事故伤药物防治研究进展

  • 海军医学研究所,上海 200433
  • 收稿日期: 2010-11-15
  • 修回日期: 2011-04-19

摘要: 随着世界各国核军备竞争的加剧,随着世界核安全形势的紧张以及核技术研究手段的不断兴起,核辐射对人类造成了极大的恐慌和伤害。如何加强核事故和核辐射损伤的应急防护和医学救治,这已经引起人们的高度重视和关注。本文针对核辐射的临床表现,从综合治疗、细胞因子、氨巯基化合物、中草药四方面,综述了目前在核事故及核辐射中药物预防与救治的研究进展,并对今后如何深入对核辐射防治药物进行开发利用进行了展望。

English Abstract

刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
引用本文: 刘玉明, 张术, 储智勇. 核辐射事故伤药物防治研究进展[J]. 药学实践与服务, 2011, 29(5): 321-323,346.
shu
LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
Citation: LIU Yu-ming, ZHANG Shu, CHU Zhi-yong. Advances on the medication of nuclear Radiation Accidents[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(5): 321-323,346.
shu

    全文HTML

参考文献 (24)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计